Loading…
Based on limited metadata, the FDA issued a Warning Letter to Panther James LLC on February 1, 2019, regarding products classified outside the standard medical device, drug, or cosmetic categories. Without access to the full letter text or specific subject line details, the precise nature of the violations cannot be determined from the available information. The issuing office is not specified in the metadata provided. To understand the specific regulatory concerns and required corrective actions, review of the complete Warning Letter would be necessary.